Navigation Links
Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
Date:12/14/2007

ith serious autoimmune and inflammatory conditions."

Alba will lead worldwide development operations through the end of Phase 2 clinical trials in Celiac disease. The companies will share responsibility for Phase 3 clinical trial execution and for the pursuit of additional indications such as Crohn's disease. This will leverage Shire's regulatory and clinical experience, as well as its commercial infrastructure.

Michael Yasick, Shire's Senior Vice President and Gastrointestinal Global Business Unit Leader added:

"We are excited about this opportunity for Shire to expand its GI franchise beyond mesalamine-related products such as Lialda(TM) / MEZAVANT XL(R). We look forward to working closely with Alba on the development of these new therapies."

Dr. Paterson also noted that, "this partnership is another step in Alba's evolution as a biopharmaceutical company and provides a significant validation of our barrier function technology platform, specifically applied to gastrointestinal disease. The partnership will also enhance our ability to provide solutions for other inflammatory and immune related diseases, both acute and chronic."

About AT-1001

AT-1001 is an inhibitor of barrier dysfunction that has been shown to block intestinal permeability and the genesis of some autoimmune diseases, both through the reduction of antigen presentation to the body's immune system and the inhibition of cytokine production. AT-1001 is orally formulated and is currently in Phase 2 studies for Celiac disease, a gastrointestinal autoimmune disease. INDs for oral AT-1001 in beta cell preservation (Type 1 Diabetes) and Crohn's disease have also been filed and cleared FDA review.

About Alba

Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical company based in Baltimore, Maryland. Alba is dedicated to development and commercialization of disease modifying therapeutics to treat autoimmune and inflammatory di
'/>"/>

SOURCE Alba Therapeutics Corporation
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...cember 2 Pepscan Holding NV,the N... protein mimicking,technology for the generation o...appointed Wim E.M. Mol, Ph.D. as new Chief Executi... for all of Pepscans corporate functions and,the o...ompany. He brings to,Pepscan more than 20 years of...
(Date:12/2/2009)...ewswire-Asia/ -- Simcere Pharmaceutical Group,("Si... pharmaceutical company,specializing in the develo...eric and proprietary pharmaceuticals in China, tod...ded in China,s National Drug Reimbursement List,("...man Resources and Social,Security on November 30, ...
(Date:12/1/2009)...nounced that he has joined Carolina Eyecare Physic...ww.DrKerrySolomon.com , which was developed by Med...SIK, lens implant, and cataract surgery expert who...ntial contributions to improving vision correction...s, which screens LASIK surgeons based upon experie...
(Date:12/1/2009)...e/ -- Harvest Technologies Corp. ( www.harvesttech...onsored 60-patient clinical trial conducted at Sri...g the company,s BMAC System to treat patients with... Sri Ramachandra Medical Center is a Harvard Medic...hennai, India and one of the largest private healt...
Breaking Biology Technology:Dutch Biotech Company Pepscan Appoints New CEO 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3
... has all the makings of a Hollywood hit a mysterio... what,s right for their community even a "leading ...ener," the film that won a Best Supporting Actress...he true-to-life story of how Abbott Laboratories I...ms, is planting a flag in Wisconsin. , ,No one kno...
... Yahoo and AOL begin charging marketers to reach t...ider the value of a customer,s inbox. One cent? 1/...d e-mail, or spam, continues to be an obstacle for...average hundreds of e-mails a day, of which only f.... Most consumers have some degree of spam filterin...
... buying BellSouth for $67 billion creates a bigger...orial about a year ago, I coined the term "revesti...like in the oligopoly that is the automobile indus...rvival: , As a country, we are progressing quickly...titure is the industry,s modern attempt to circle ...
Other Biology Technology:Theres more than a bit of mystery, but attracting 'Big Pharma' is good for the state 2Theres more than a bit of mystery, but attracting 'Big Pharma' is good for the state 3What's an inbox worth? 2What's an inbox worth? 3What's an inbox worth? 4Old bell system merging back together, but it's not the same 2Old bell system merging back together, but it's not the same 3Old bell system merging back together, but it's not the same 4
(Date:12/3/2009)... new information and adapt to changes in our daily...es, appears to lie in the minute junctions where n...y NYU Langone Medicine Center researchers. The stu...ature . , The scientists, led by Wen-Biao Gan, ...ience at NYU School of Medicine, discovered that a...
(Date:12/3/2009)...ts 32nd year, the CTRC-AACR San Antonio Breast Can...ast cancer science and world leaders from industry...cancer. , This year, more than 8,500 scientists...B. Gonzales Convention Center in San Antonio from ...tween the American Association for Cancer Research...
(Date:12/3/2009)...rly upset by a social snubbing? Your genetics, not...e long known that opium-like painkillers, called o...ome forms of emotional stress. Now, a new study re...ilig shows that small genetic differences in the g...nsity of people,s responses to social rejection. ...
Breaking Biology News(10 mins):Lifelong memories linked to stable nerve connections 2CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Avantium to Deliver Flowrence System to Pacific Northwest National Laboratory 28PNNL 29 USA 12762 1Avantium to Deliver Flowrence System to Pacific Northwest National Laboratory 28PNNL 29 USA 12762 2RIEMSER Announces Upcoming Chicago Bone Grafting Workshop 49894 1RIEMSER Announces Upcoming Chicago Bone Grafting Workshop 49894 2Hypoallergenic Cat Company Launches Pet Buddies Program to Donate Its Unique Kittens to Pet Allergic Children Undergoing Long Term Medical Treatment 49892 1Hypoallergenic Cat Company Launches Pet Buddies Program to Donate Its Unique Kittens to Pet Allergic Children Undergoing Long Term Medical Treatment 49892 2
...of the reign of a honey bee queen appears to be de...she mates with drone bees. , That is what resear...nd W.M. Keck Center for Behavioral Biology at Nort...Jeanne Richard, a post-doctoral research associate...arolina Cooperative Extension apiculturist; and Dr...
...first, the chicken genome or the egg genome? , Re...r more relevant) genomic question: Which of the th...uman genome came first? And which are the duplicat...netics on October 7, 2007, provide the first evol...genome that are partly responsible for both diseas...
...-- Corazonas Foods, Inc., creators of great-tastin...lusive licensing agreement with Brandeis Universit...w categories of heart-healthy snacks. Brandeiss i...terols to be incorporated into snack foods while r...tnerships first venture, Corazonas Heart-Healthy T...
Other Biology News:For honey bee queens, multiple mating makes a difference 2For honey bee queens, multiple mating makes a difference 3Which came first, the chicken genome or the egg genome? 2Which came first, the chicken genome or the egg genome? 3Corazonas Foods and Brandeis University partner to create cholesterol-reducing snacks 2
FMK Negative Control from BioVision
...romatographically purified from egg white. The ext...product is in 10 mM phosphate-buffered saline, p...sodium azide and 50% glycerol. Avidin (from egg wh...rified by molecular sieving and is completely f...
Amino Acid Mixture, Complete from Promega
Streptavidin, Fluorescein conjugated/tagged from R&D Systems
Biology Products: